Abstract
Shigella flexneri is a Gram-negative bacillus that is responsible for a severe form of dysentery called Shigellosis, which mainly affects children and the elderly in both underdeveloped and developed countries. Pathogenic S. flexneri strains possess a large virulence plasmid that codes for effector proteins that are required for the entry and spread of the bacteria into colonocytes. Among these proteins is the translocator IpaC, which plays an important role in the invasion process; IpaC is implicated in pore formation in the host cell membrane and induces cytoskeletal rearrangements in macrophages and epithelial cells, thereby promoting bacterial entry. The ability of IpaC to insert into the plasma membrane is due to a large nonpolar region of the protein structure. This characteristic also renders difficulties in recovery and purification when the protein is expressed in E. coli. Several works have considered different methodologies for the improved production and purification of IpaC. Herein, we propose an alternative method that is based on changes in the induction temperature and extraction buffer to facilitate the accumulation of high yields of soluble proteins for their further processing and ultimate use in biotechnological approaches.
Keywords: Shigella flexneri, IpaC production, purification, shigellosis, vaccines
Protein & Peptide Letters
Title:Cloning and Purification of IpaC Antigen from Shigella flexneri: Proposal of a New Methodology
Volume: 20 Issue: 2
Author(s): Cristiane Mobilon, Marcelo Augusto Szymanski de Toledo, Fernanda Laroza Paganelli, Clelton Aparecido dos Santos, Fernanda de Pace, Jacqueline Boldrin de Paiva, Eliana Guedes Stehling, Gerson Nakazato, Aline Gambaro Balieiro, Flavia Pereira da Silva Airoldi, Francisco de Assis Machado Reis and Wanderley Dias da Silveira
Affiliation:
Keywords: Shigella flexneri, IpaC production, purification, shigellosis, vaccines
Abstract: Shigella flexneri is a Gram-negative bacillus that is responsible for a severe form of dysentery called Shigellosis, which mainly affects children and the elderly in both underdeveloped and developed countries. Pathogenic S. flexneri strains possess a large virulence plasmid that codes for effector proteins that are required for the entry and spread of the bacteria into colonocytes. Among these proteins is the translocator IpaC, which plays an important role in the invasion process; IpaC is implicated in pore formation in the host cell membrane and induces cytoskeletal rearrangements in macrophages and epithelial cells, thereby promoting bacterial entry. The ability of IpaC to insert into the plasma membrane is due to a large nonpolar region of the protein structure. This characteristic also renders difficulties in recovery and purification when the protein is expressed in E. coli. Several works have considered different methodologies for the improved production and purification of IpaC. Herein, we propose an alternative method that is based on changes in the induction temperature and extraction buffer to facilitate the accumulation of high yields of soluble proteins for their further processing and ultimate use in biotechnological approaches.
Export Options
About this article
Cite this article as:
Mobilon Cristiane, Augusto Szymanski de Toledo Marcelo, Laroza Paganelli Fernanda, Aparecido dos Santos Clelton, de Pace Fernanda, Boldrin de Paiva Jacqueline, Guedes Stehling Eliana, Nakazato Gerson, Gambaro Balieiro Aline, Pereira da Silva Airoldi Flavia, de Assis Machado Reis Francisco and Dias da Silveira Wanderley, Cloning and Purification of IpaC Antigen from Shigella flexneri: Proposal of a New Methodology, Protein & Peptide Letters 2013; 20 (2) . https://dx.doi.org/10.2174/0929866511320020003
DOI https://dx.doi.org/10.2174/0929866511320020003 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Drugs and Rhabdomyolysis: From Liver to Kidney
Current Vascular Pharmacology Pathophysiology of Blood-Spinal Cord Barrier in Traumatic Injury and Repair
Current Pharmaceutical Design Latest Therapeutic Novelties and Patents in Pulmonary Hypertension
Recent Patents on Cardiovascular Drug Discovery Clinical Review of COVID-19; Pathogenesis, Diagnosis, and Management
Current Pharmaceutical Design Myalgic Encephalomyelitis: Symptoms and Biomarkers
Current Neuropharmacology Role of Sympathetic Nerve Activity in Obesity, Hypertension and Metabolic Syndrome
Current Hypertension Reviews Free Fatty Acids: Circulating Contributors of Metabolic Syndrome
Cardiovascular & Hematological Agents in Medicinal Chemistry Preventive Strategies for Ventilator Associated Pneumonia
Current Respiratory Medicine Reviews Calcium Imaging in C. elegans with Emphasis on Locomotion as a Model
Current Molecular Imaging (Discontinued) Targeting Striatal Metabotropic Glutamate Receptor Type 5 in Parkinson’s Disease: Bridging Molecular Studies and Clinical Trials
CNS & Neurological Disorders - Drug Targets FoxO1 Inhibitors: The Future Medicine for Metabolic Disorders?
Current Diabetes Reviews A Review of Maternal and Fetal Growth Factors in Diabetic Pregnancy
Current Diabetes Reviews Perioperative Management of Intracranial Aneurysm and Subarachnoid Hemorrhage
Current Pharmaceutical Design Effects of Amine Oxidases in Allergic and Histamine-Mediated Conditions
Recent Patents on Inflammation & Allergy Drug Discovery Hypothyroidism and Cardiovascular Disease: Factors, Mechanism and Future Perspectives
Current Medicinal Chemistry PET Imaging of Beta-Adrenoceptors in Human Brain: A Realistic Goal or a Mirage?
Current Pharmaceutical Design GABA Puts a Stop to Pain
Current Drug Targets - CNS & Neurological Disorders Myostatin Inhibition and Cardiometabolic Disorders
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Endurance Exercise Training and Reproductive Endocrine Dysfunction in Men Alterations in the Hypothalamic-Pituitary-Testicular Axis
Current Pharmaceutical Design The Importance of Early Diagnosis and Treatment in Peripheral Arterial Disease: Insights from the PARTNERS and REACH Registries
Current Vascular Pharmacology